X |
Filing Date |
Trade Date |
Ticker |
Company Name | Industry | Ins |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 | 2026-01-09 | ADC | Agree Realty Corp | Real Estate Investment Trusts | 3 | P - Purchase | $71.23 | +39,500 | 1,241,225 | +3% | +$2,813,680 | |||||
| 40 M | 2026-01-07 | TPVG | Triplepoint Venture Growth Bdc Corp. | Closed-End Funds | 2 | P - Purchase | $6.36 | +2,784,910 | 4,464,010 | +166% | +$17,711,198 | |||||
| 2 | 2026-01-05 | LB | Landbridge Co LLC | Oil Royalty Traders | 2 | P - Purchase | $46.66 | +2,993 | 290,420 | +1% | +$139,656 | |||||
| 3 | 2026-01-05 | WBI | Waterbridge Infrastructure LLC | Oil & Gas Field Services | 3 | P - Purchase | $20.13 | +11,865 | 314,365 | +4% | +$238,844 | |||||
| 5 M | 2025-12-31 | HYPD | Hyperion Defi, Inc. | Pharmaceutical Preparations | 4 | P - Purchase | $3.23 | +189,204 | 698,493 | +37% | +$611,458 | |||||
| 2 M | 2025-11-06 | LTC | Ltc Properties Inc | Real Estate Investment Trusts | 2 | P - Purchase | $34.80 | +15,000 | 55,460 | +37% | +$521,960 | |||||
| 3 M | 2025-12-31 | LSAK | Lesaka Technologies Inc | Functions Related to Depository Banking | 2 | P - Purchase | $4.99 | +1,830,500 | 2,575,615 | +246% | +$9,130,204 | |||||
| 2 M | 2025-12-30 | MDBH | Mdb Capital Holdings, LLC | Finance Services | 2 | P - Purchase | $3.41 | +16,935 | 264,868 | +7% | +$57,683 | |||||
| 4 | 2025-12-19 | IMNM | Immunome Inc. | Pharmaceutical Preparations | 2 | P - Purchase | $21.22 | +68,518 | 896,547 | +8% | +$1,453,958 | |||||
| 4 | 2025-12-29 | NKE | Nike, Inc. | Rubber & Plastics Footwear | 4 | P - Purchase | $59.77 | +91,229 | 413,328 | +28% | +$5,452,641 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-01-09 | ADC | Agree Realty Corp | Coughenour Peter | CFO | P - Purchase | $69.80 | +500 | 18,544 | +3% | +$34,900 | ||||||
2026-01-08 | ALMS | Alumis Inc. | Foresite Labs, LLC | 10% | P - Purchase | $17.00 | +411,764 | 10,487,268 | +4% | +$6,999,988 | ||||||
2026-01-08 | ALMS | Alumis Inc. | Foresite Capital Management VI LLC | 10% | P - Purchase | $17.00 | +411,764 | 10,487,268 | +4% | +$6,999,988 | ||||||
2026-01-08 | ALMS | Alumis Inc. | Tananbaum James B. | Dir, 10% | P - Purchase | $17.00 | +411,764 | 10,487,268 | +4% | +$6,999,988 | ||||||
| M | 2026-01-07 | NYC | American Strategic Investment Co. | Schorsch Nicholas S | 10% | P - Purchase | $9.08 | +4,128 | 1,604,161 | 0% | +$37,487 | |||||
| D | 2026-01-12 | AKTS | Aktis Oncology, Inc. | Ecor1 Capital, LLC | Dir | P - Purchase | $18.00 | +2,222,222 | 347,305 | -119% | +$39,999,996 | |||||
2026-01-08 | PDX | Pimco Dynamic Income Strategy Fund | Rappaport Alan | Dir | P - Purchase | $18.97 | +2,000 | 3,000 | +200% | +$37,946 | ||||||
| D | 2026-01-12 | AKTS | Aktis Oncology, Inc. | Vida Ventures Ii, LLC | 10% | P - Purchase | $18.00 | +835,000 | 157,387 | -123% | +$15,030,000 | |||||
| D | 2026-01-12 | AKTS | Aktis Oncology, Inc. | Kim Helen Susan | Dir, 10% | P - Purchase | $18.00 | +835,000 | 157,387 | -123% | +$15,030,000 | |||||
2026-01-09 | TCGSX | Tcg Strategic Income Fund | Tannenbaum Leonard M | Dir, 10% | P - Purchase | $10.14 | +93,688 | 101,808 | >999% | +$950,000 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-01-09 | MIGI | Mawson Infrastructure Group Inc. | Endeavor Blockchain, LLC | 10% | P - Purchase | $4.56 | +182,018 | 85,297 | -188% | +$829,562 | |||||
| M | 2025-12-26 | MIGI | Mawson Infrastructure Group Inc. | Endeavor Blockchain, LLC | 10% | P - Purchase | $4.48 | +205,000 | 63,279 | -145% | +$917,550 | |||||
2026-01-07 | GTE | Gran Tierra Energy Inc. | Lm Asset (Im) Inc. | 10% | P - Purchase | $3.87 | +80,000 | 4,381,750 | +2% | +$309,712 | ||||||
| M | 2026-01-07 | YYAI | Airwa Inc. | Zhou Hongyu | Dir | P - Purchase | $1.16 | +189,097 | 491,567 | +63% | +$219,807 | |||||
2026-01-07 | SQNS | Sequans Communications | Asher Daniel | 10% | P - Purchase | $4.91 | +21,900 | 1,706,847 | +1% | +$107,514 | ||||||
2026-01-06 | IVFH | Innovative Food Holdings Inc | Smith Denver Johnson | Dir | P - Purchase | $0.30 | +505,555 | 4,844,130 | +12% | +$151,667 | ||||||
2026-01-06 | IVFH | Innovative Food Holdings Inc | Schmulen Mark | Dir | P - Purchase | $0.30 | +288,890 | 345,234 | +513% | +$86,667 | ||||||
2026-01-08 | COSM | Cosmos Health Inc. | Siokas Grigorios | CEO, 10% | P - Purchase | $0.52 | +156,190 | 7,131,794 | +2% | +$81,000 | ||||||
2026-01-06 | IVFH | Innovative Food Holdings Inc | Pappas James C | Dir, 10% | P - Purchase | $0.30 | +505,555 | 10,414,722 | +5% | +$151,667 | ||||||
2025-12-31 | ZNTL | Zentalis Pharmaceuticals, Inc. | Walters Group | 10% | P - Purchase | $1.20 | +6,459,973 | 13,509,973 | +92% | +$7,751,968 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-01-12 | ACLX | Arcellx, Inc. | Heery Christopher | CHIEF MEDICAL OFFICER | S - Sale | $64.15 | -6,131 | 37,068 | -14% | -$393,286 | ||||||
| DM | 2026-01-09 | LIND | Lindblad Expeditions Holdings, Inc. | Bressler Benjamin | *Founder, CEO of NHA | S - Sale+OE | $15.83 | -291,825 | 23,466 | -93% | -$4,620,124 | |||||
| M | 2026-01-08 | BBIO | Bridgebio Pharma, Inc. | Kumar Neil | CEO | S - Sale | $75.54 | -80,000 | 5,462,909 | -1% | -$6,043,168 | |||||
| D | 2026-01-12 | ZYME | Zymeworks Inc. | Smith Jeffrey T L | EVP, Chief Medical Officer | S - Sale+OE | $22.67 | -9,310 | 26,708 | -26% | -$211,090 | |||||
| D | 2026-01-12 | ZYME | Zymeworks Inc. | Moore Paul Andrew | Chief Scientific Officer | S - Sale+OE | $22.67 | -9,560 | 48,497 | -16% | -$216,759 | |||||
| M | 2026-01-08 | LXU | Lsb Industries, Inc. | Golsen Barry H | Dir | S - Sale | $9.16 | -175,697 | 277,674 | -39% | -$1,609,380 | |||||
| M | 2026-01-08 | KTOS | Kratos Defense & Security Solutions, Inc. | Rock Stacey G | Pres, KTT Division | S - Sale | $114.53 | -20,568 | 26,487 | -44% | -$2,355,667 | |||||
| D | 2026-01-08 | RDDT | Reddit, Inc. | Slowe Christopher Brian | CTO | S - Sale+OE | $253.89 | -14,000 | 189,878 | -7% | -$3,554,387 | |||||
| D | 2026-01-12 | ZYME | Zymeworks Inc. | Galbraith Kenneth | Chair, CEO | S - Sale+OE | $22.67 | -30,424 | 226,842 | -12% | -$689,819 | |||||
| D | 2026-01-08 | LUNR | Intuitive Machines, Inc. | Altemus Stephen J | CEO, 10% | S - Sale+OE | $20.00 | -12,669 | 13,855,946 | 0% | -$253,419 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-01-09 | ADC | Agree Realty Corp | Coughenour Peter | CFO | P - Purchase | $69.80 | +500 | 18,544 | +3% | +$34,900 | ||||||
2026-01-08 | ALMS | Alumis Inc. | Foresite Labs, LLC | 10% | P - Purchase | $17.00 | +411,764 | 10,487,268 | +4% | +$6,999,988 | ||||||
2026-01-08 | ALMS | Alumis Inc. | Foresite Capital Management VI LLC | 10% | P - Purchase | $17.00 | +411,764 | 10,487,268 | +4% | +$6,999,988 | ||||||
2026-01-08 | ALMS | Alumis Inc. | Tananbaum James B. | Dir, 10% | P - Purchase | $17.00 | +411,764 | 10,487,268 | +4% | +$6,999,988 | ||||||
2026-01-12 | ACLX | Arcellx, Inc. | Heery Christopher | CHIEF MEDICAL OFFICER | S - Sale | $64.15 | -6,131 | 37,068 | -14% | -$393,286 | ||||||
| DM | 2026-01-09 | LIND | Lindblad Expeditions Holdings, Inc. | Bressler Benjamin | *Founder, CEO of NHA | S - Sale+OE | $15.83 | -291,825 | 23,466 | -93% | -$4,620,124 | |||||
| A | 2026-01-11 | AEHR | Aehr Test Systems | Richmond Donald P. II | VP OF ENGINEERING | F - Tax | $26.32 | -486 | 213,677 | 0% | -$12,792 | |||||
| M | 2026-01-07 | NYC | American Strategic Investment Co. | Schorsch Nicholas S | 10% | P - Purchase | $9.08 | +4,128 | 1,604,161 | 0% | +$37,487 | |||||
| M | 2026-01-08 | BBIO | Bridgebio Pharma, Inc. | Kumar Neil | CEO | S - Sale | $75.54 | -80,000 | 5,462,909 | -1% | -$6,043,168 | |||||
| D | 2026-01-12 | ZYME | Zymeworks Inc. | Smith Jeffrey T L | EVP, Chief Medical Officer | S - Sale+OE | $22.67 | -9,310 | 26,708 | -26% | -$211,090 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |